PrEPVacc
PrEP Vacc Registration Cohort Get Involved Contact Member's Area
Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive
Partners Organisation and Governance Our Funders FAQs
PrEPVaccRegistration CohortGet Involved News Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive About Partners Organisation and Governance Our Funders FAQs ContactMember's Area
PrEPVacc
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024

News from Muhimbili University of Health and Allied Sciences

Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
3 December 2024
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
3 December 2024
3 December 2024
FAQs for PrEPVacc's vaccine result
5 August 2024
FAQs for PrEPVacc's vaccine result
5 August 2024
5 August 2024
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
23 July 2024
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
23 July 2024
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
23 July 2024
23 July 2024
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
23 July 2024
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
23 July 2024
23 July 2024
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with  second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
23 July 2024
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
23 July 2024
23 July 2024
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
11 January 2024
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
11 January 2024
11 January 2024
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
4 December 2023
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
4 December 2023
4 December 2023
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
9 June 2023
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
9 June 2023
9 June 2023
Video to help inform PrEPVacc participants posted online
31 March 2023
Video to help inform PrEPVacc participants posted online
31 March 2023
31 March 2023
03-Yellow_EDCTP.png
flag_yellow_low.jpg
 

This project is part of the EDCTP2 Programme supported by the European Union

 
prepvacc@gmail.com
Hours
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
Joining the studyFAQs Partners of PrEPVacc
PrEPVacc-logo-reverse-rgb.png
 

Contact: prepvacc@gmail.com | Accessibility

© PrEPVacc Investigators 2026 | All rights reserved